Risk analysis is not yet available for this country's tenders. Currently supported: Estonia, Latvia, Lithuania, Poland, France, UK, Denmark, Netherlands, Norway, and Finland.
Get an AI-powered winning strategy tailored to this tender. Includes win probability score, key opportunities and challenges, recommended bid focus areas, competitive positioning insights, and actionable recommendations to maximize your chances.
LoginUpgrade to see which companies are likely to bid on this tender, based on historical procurement data.
LoginAI extracts and organizes all requirements from tender documents — mandatory qualifications, technical specifications, financial conditions, and submission rules — clearly categorized so you know exactly what's needed to bid.
Login3 documents available with AI summaries
This OCDS Record provides structured data about a tender initiated by The Royal Marsden NHS Foundation Trust for the provision of radiopharmaceuticals, detailing an award and contract.
This OCDS Release Package provides structured data detailing a negotiated procurement for the provision of radiopharmaceuticals by The Royal Marsden NHS Foundation Trust, including information about the contracting parties and the tender's status.
This is an award notice for a direct award contract for the provision of radiopharmaceuticals to GE Healthcare Ltd by The Royal Marsden NHS Foundation Trust, valued at £120,000, running from March 2026 to March 2028.
Sign up to view document summaries and analysis
Comprehensive quality analysis of this tender scoring legal compliance, clarity, completeness, fairness, practicality, data consistency, and sustainability on a 0-100 scale with detailed breakdown and recommendations.
LoginHello! I'm your AI assistant for this tender. I can help you understand requirements, deadlines, eligibility criteria, and provide strategic insights.
No credit card required